Here's a rapid-fire update on every stock in the CNBC Investing Club portfolio. Jim Cramer ran through each one of them on Thursday during the January edition of our "Monthly Meeting." Apple — We are still firmly in the "own it, don't trade it" camp. The iPhone maker reports earnings in the first week of February. If the stock falls below $120 ahead of the print, that could be an opportunity to buy some shares.
That's in line with our mantra of owning companies that make stuff at a profit and return some of it to shareholders. Humana — Humana is doing very well, evidenced by its recent outlook revision. The health insurer now estimates its Medicare Advantage enrollment will grow by at least 625,000 members in 2023, up from prior guidance of 500,000. Johnson & Johnson — J & J is a buy here. The stock has kind of been stagnant over the past six months or so.
This guy is hopeless!! Popular doesnt mean good